Randomized Trial of Anti-D Immunoglobulin versus Low-Dose Intravenous Immunoglobulin in the Treatment of Childhood Chronic Idiopathic Thrombocytopenic Purpura

Publisher： Karger

E-ISSN： 1421-9662|115|1-2|46-52

ISSN： 0001-5792

Source： Acta Haematologica, Vol.115, Iss.1-2, 2006-01, pp. : 46-52

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparison of Cytokine Responses with Anti-D and Intravenous Immunoglobulin in Idiopathic Thrombocytopenia

By  

Transfusion Medicine and Hemotherapy, Vol. 40, Iss. 1, 2013-01 ,pp. : 49-49

Karger

Access to resources Recommend Favorite

Efficacy and Safety of the New Intravenous Immunoglobulin IGIV 10% in Adults with Chronic Idiopathic Thrombocytopenic Purpura

By  

Transfusion Medicine and Hemotherapy, Vol. 33, Iss. 6, 2006-10 ,pp. : 509-514

Karger

Access to resources Recommend Favorite

Autoantibody Level Modification in Adult Patients with Idiopathic Thrombocytopenic Purpura following Intravenous Immunoglobulin Treatment

By  

Natural Immunity, Vol. 16, Iss. 5-6, 2000-09 ,pp. : 207-214

Karger

Access to resources Recommend Favorite

Rapid Encephalopathy Associated with Anti-D Immune Globulin Treatment for Idiopathic Thrombocytopenic Purpura

By  

Acta Haematologica, Vol. 120, Iss. 2, 2008-10 ,pp. : 100-103

Karger

Access to resources Recommend Favorite

Headache and Nausea after Treatment with High‐Dose Subcutaneous versus Intravenous Immunoglobulin

By  

BASIC AND CLINICAL PHARMACOLOGY & TOXICOLOGY (ELECTRONIC), Vol. 117, Iss. 6, 2015-12 ,pp. : 409-412

John Wiley & Sons Inc

Access to resources Recommend Favorite